Continuous Peripheral Nerve Blocks (CPNB)
JJ · Effective Jan 29, 2018
48 active Medicare policies list G89.29, and 19 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
J9 · Effective Oct 11, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
19 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 15 · All Aetna policies
| Policy | Effective | Status of G89.29 |
|---|---|---|
| Cerebral Perfusion Studies | Sep 14, 2023 | Covered |
| Complex Regional Pain Syndrome (CRPS): Treatments | Feb 27, 2024 | Covered |
| Cryoanalgesia and Therapeutic Cold | Mar 16, 2023 | Covered |
| Eye Movement Desensitization and Reprocessing (EMDR) Therapy | Sep 7, 2023 | Covered |
| Laboratory Tests for Depression and Other Psychiatric Disorders | Feb 27, 2024 | Covered |
| Magnetic Source Imaging/Magnetoencephalography |
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Mar 31, 2024
JM · Effective Mar 31, 2024
J15 · Effective Oct 5, 2015
J6 · Effective Dec 24, 2023
JK · Effective Dec 24, 2023
JE · Effective Jun 28, 2016
JF · Effective Jun 28, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
National · Effective Oct 1, 2025
J9 · Effective Oct 1, 2024
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
JL · Effective Oct 1, 2025
J5 · Effective Jan 1, 2026
J5 · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
National · Effective Jan 1, 2026
National · Effective Jun 1, 2026
National · Effective Jun 1, 2026
National · Effective Apr 16, 2026
J5 · Effective Jun 1, 2026
J6 · Effective Jun 1, 2026
| May 4, 2023 |
| Covered |
| Motor Cortex Stimulation | Oct 6, 2023 | Covered |
|---|
| Peripheral Electrical Nerve Stimulation for Pain | Feb 8, 2024 | Covered |
|---|
| Pharmacogenetic and Pharmacodynamic Testing | Feb 27, 2024 | Covered |
|---|
| Pulsed Electromagnetic Stimulation | Mar 14, 2023 | Covered |
|---|
| Policy | Effective | Status of G89.29 |
|---|---|---|
| Trigger Point Injections | Jul 1, 2026 | Covered |
| Policy | Effective | Status of G89.29 |
|---|---|---|
| Peripheral Nerve Destruction for Pain Conditions | Sep 15, 2026 | Not covered |
| Policy | Effective | Status of G89.29 |
|---|---|---|
| Injections for Chronic Pain Conditions | Jul 15, 2026 | Covered |
| Policy | Effective | Status of G89.29 |
|---|---|---|
| Hysterectomy | Jul 1, 2026 | Covered |